Reinhard Dummer is Deputy Clinical Director of the Department of Dermatology at the University Hospital of Zurich, Switzerland. Recognized as a world leader in Cutaneous Oncology, he heads the Skin Cancer Unit and the Clinical Trials Unit in his department. With initial training in Hematology, he completed his residency in Dermatology in Würzburg, Germany, and in Switzerland. He is also board certified in Allergology, Clinical Immunology, Dermatology and Dermatopathology.

Throughout his career, Dr. Dummer has specialized in the Molecular Biology and Immunotherapy of skin tumors, including Lymphomas and Melanomas. He has published more than a thousand scientific articles, accumulating a very high impact factor in his research publications. Also, as a pioneer in Translational Medicine, he has participated in key studies on inhibitors such as Ipilimumab, and others selective of the BRAF oncogene, such as Vemurafenib. Thanks to these innovations, he and his team have achieved significant advances in the approach to skin metastasis.

In addition, this expert has received awards such as the first Translation Prize of the German Cancer Society. The award is a recognition of Dr. Dummer's ability to rapidly apply the results of preclinical research, obtained by other specialists, in his regular clinical practice. In turn, as an advocate of Personalized Medicine, one of his working premises has been to investigate the analysis of individual genetic material to optimize therapeutic benefits and minimize side effects in patients.

On the other hand, the scientist has been president of the Melanoma Project Group of the Swiss Institute for Applied Cancer Research. He is also a member of the German National Academy of Sciences and has been a member of the Board of Directors of the International Society for Melanoma Research and President of the International Cutaneous Lymphoma Society.

• Deputy Clinical Director, Department of Dermatology, University Hospital Zurich, Switzerland
• Head of the Cutaneous Tumor Center of the University Hospital Zurich
• Professor of Dermatology, Faculty of Medicine, University of Zurich, Switzerland
• Attending Physician in Oncology at the University Hospital of the Ruprecht-Karls University Heidelberg
• Doctorate at the Medical Faculty of the Julius-Maximilians-University Würzburg, Germany
• President of the International Society for Cutaneous Lymphoma (ISCL)
• Co-founder of the Board of Directors of the European Association of Dermato-Oncology
• Member of:
  • European Academy of Sciences
  • European Society for Medical Oncology
  • Steering Committee of the Society for Melanoma Research
  • Austrian Society of Dermatology and Venereology
  • German National Academy of Sciences
  • German Cancer Society